SCHEMBL166697

SCHEMBL166697

C1=C[C]2CCC2CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878584 0.85
SCHEMBL12465603 0.83 ALDH1A1 (0.34)
SCHEMBL2878672 0.83 MAOA (0.33)
SCHEMBL19463253 0.81
SCHEMBL167989 0.78
SCHEMBL1524597 0.77
SCHEMBL166398 0.76
SCHEMBL2540038 0.75 ALDH1A1 (0.36)
SCHEMBL7783727 0.73 ALDH1A1 (0.39)
SCHEMBL12467506 0.73 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130498-A1 AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF DEUTSHES INSTITUT FUR ERNAHRUNGSFORSCHUNG POTSDAM- REHBRUCKE (DE) 2010-05-27 US claimed
EP-2132564-A2 AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke Stiftung des Öffentlichen Rechts (DE) 2009-12-16 EP claimed
WO-2008119527-A2 AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POSTDAM-REHBRÜCKE STIFTUNG DES ÖFFENTLICHEN RECHTS (DE) 2008-10-09 WO claimed
EP-1975611-A1 Agonists of bitter taste receptors and uses thereof Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand (DE) 2008-10-01 EP claimed
WO-2024149728-A1 SUBSTITUTED (HETERO)ANILINES AND THEIR USE ASTRAZENECA AB (SE) 2024-07-18 WO disclosed
US-20230120294-A1 ANTIVIRAL AGENTS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION PHARMASYNTEZ, JOINT STOCK COMPANY (RU) 2023-04-20 US disclosed
EP-4107156-A1 PYRIMIDINE-BASED BICYCLES AS ANTIVIRAL AGENTS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION Joint Stock Company "Pharmasyntez" (RU) 2022-12-28 EP disclosed
EP-3808743-B1 HIV REPLICATION INHIBITING PYRIMIDINES JANSSEN PHARMACEUTICA NV (BE) 2022-07-20 EP disclosed
US-11236122-B2 Triterpene amine derivatives DFH THERAPEUTICS (US) 2022-02-01 US disclosed
US-20210253627-A1 TRITERPENE AMINE DERIVATIVES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2021-08-19 US disclosed
EP-3808743-A1 HIV REPLICATION INHIBITING PYRIMIDINES Janssen Pharmaceutica NV (BE) 2021-04-21 EP disclosed
EP-3796900-A1 TRITERPENE AMINE DERIVATIVES DFH Therapeutics (US) 2021-03-31 EP disclosed
EP-1442024-A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2004-08-04 EP disclosed
EP-1442019-A1 AMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3-BETA INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2004-08-04 EP disclosed
EP-1419152-A1 HIV INHIBITING PYRIMIDINES DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2004-05-19 EP disclosed
WO-2003037869-A1 AMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3-BETA INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-05-08 WO disclosed
WO-2003037891-A1 HETEROARYL AMINES AS GLYCOGEN SYNTHASE KINASE 3BETA INHIBITORS (GSK3 INHIBITORS) JANSSEN PHARMACEUTICA N.V. (BE) 2003-05-08 WO disclosed
WO-2003037877-A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-05-08 WO disclosed
WO-2003016306-A1 HIV INHIBITING PYRIMIDINES DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 2003-02-27 WO disclosed
US-4552888-A Ascorbic acid ethers in angiogene ELI LILLY AND COMPANY (US) 1985-11-12 US disclosed